About Alector
Alector is a company based in San Francisco (United States) founded in 2013.. Alector has raised $214.78 million across 6 funding rounds from investors including AbbVie, New Leaf Venture Partners and HHS. The company has 211 employees as of December 31, 2022. Alector offers products and services including AL101/GSK4527226 and Pipeline Therapies. Alector operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter San Francisco, United States
- Employees 211 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alector, Inc.
-
Annual Revenue
$100.56 M4as on Dec 31, 2024
-
Net Profit
$-119.05 M9as on Dec 31, 2024
-
EBITDA
$-145 M4as on Dec 31, 2024
-
Total Equity Funding
$214.78 M (USD)
in 6 rounds
-
Latest Funding Round
$133 M (USD), Series E
Jul 25, 2018
-
Investors
AbbVie
& 19 more
-
Employee Count
211
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Alector
Alector is a publicly listed company on the NASDAQ with ticker symbol ALEC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Alector
Alector offers a comprehensive portfolio of products and services, including AL101/GSK4527226 and Pipeline Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug for early Alzheimer's disease treatment in clinical trials.
Candidates targeting FTD and ALS for disease modification.
Unlock access to complete
Leadership Team
24 people
Software Development Team
17 people
Scientific Team
8 people
Finance and Accounting
7 people
Senior Team
5 people
Product Management Team
5 people
Data Analysis and Operations Team
5 people
Operations Team
5 people
Unlock access to complete
Funding Insights of Alector
Alector has successfully raised a total of $214.78M across 6 strategic funding rounds. The most recent funding activity was a Series E round of $133 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series E — $133.0M
- First Round First Round
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2018 | Amount | Series E - Alector | Valuation |
investors |
|
| Oct, 2017 | Amount | Series D - Alector | Valuation | AbbVie |
|
| Sep, 2016 | Amount | Grant - Alector | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alector
Alector has secured backing from 20 investors, including venture fund and institutional investors. Prominent investors backing the company include AbbVie, New Leaf Venture Partners and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location | |
|
Stage-agnostic investments in US life sciences are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alector
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alector
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alector Comparisons
Competitors of Alector
Alector operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alector
Frequently Asked Questions about Alector
When was Alector founded?
Alector was founded in 2013.
Where is Alector located?
Alector is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Alector a funded company?
Alector is a funded company, having raised a total of $214.78M across 6 funding rounds to date. The company's 1st funding round was a Grant of $1.45M, raised on Oct 31, 2013.
How many employees does Alector have?
As of Dec 31, 2022, the latest employee count at Alector is 211.
What is the annual revenue of Alector?
Annual revenue of Alector is $100.56M as on Dec 31, 2024.
What does Alector do?
Alector was founded in 2013 and is headquartered in San Francisco, United States. Immuno-modulatory therapies targeting dementia and other neurodegenerative disorders are developed by the company. Antibody drugs engaging neuro-immune targets validated genetically are included in the pipeline. Drug candidates such as AL001 for dementia, AL101 for neurology, AL002 and AL003 for Alzheimers, AL014 for Alzheimers, and AL008 for oncology are advanced. Operations focus on biotechnology within the healthcare sector.
Who are the top competitors of Alector?
Alector's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Alector offer?
Alector offers AL101/GSK4527226 and Pipeline Therapies.
Is Alector publicly traded?
Yes, Alector is publicly traded on NASDAQ under the ticker symbol ALEC.
Who are Alector's investors?
Alector has 20 investors. Key investors include AbbVie, New Leaf Venture Partners, HHS, Orbimed, and Perceptive Advisors.
What is Alector's ticker symbol?
The ticker symbol of Alector is ALEC on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.